Seraseq® Tri-Level Tumor Mutation DNA Mix v2 HC
€3,232.00
Delivery time: 1 to 2 weeks
Product number:
0710-0097
Product information "Seraseq® Tri-Level Tumor Mutation DNA Mix v2 HC"
Single-sample format for daily run use, 40 unique multiplexed variants across 28 genes at allele frequencies distributed at 4%, 7% or 10%, 20 SNVs, 5 SNVs that are part of homopolymers, 13 indels, 2 SVs. Mutation targets quantitated with digital PCR, well-characterized GM24385 human genomic DNA as background ‘wild-type’ material. Manufactured under cGMP within ISO 9001 and ISO 13485 certified facilities. The Seraseq Tumor Mutation DNA Mix v2 (AF7) HC is formulated for use with targeted next-generation sequencing (NGS) assays that detect mutations in key oncogenes and tumor suppressor genes. The Seraseq Tumor Mutation DNA Mix v2 (AF7) HC is intended as a quality reference material for translational and disease research testing to monitor library preparation, sequencing, and variant allele detection under a given set of bioinformatics pipeline parameters.
| Product type: | Control & reference materials |
|---|---|
| Regulatory status: | RUO |
| Content: | 25 ng/µl |
| Quantity: | 1 x 25 µl |
| Storage temperature: | -20 °C |
| Shipping method: | Dry ice |
| Country of distribution: | Germany, Austria |